Starling (YC W22)

Starling (YC W22)

An AI-powered at home urology remote patient monitoring platform

Founded 2019

Houston, United States 12 employees Seed Total: $4.23M Health Care, Medical Devices

Starling Medical is an innovative startup founded in 2019 that aims to revolutionize urology remote patient monitoring with its AI-powered platform. Positioned as an at-home solution, it seamlessly integrates into the user's bathroom routine. By monitoring changes in urine over time, Starling Medical seeks to bring the benefits of remote monitoring to a wider range of chronic conditions such as recurrent UTIs, BPH, and chronic kidney disease. The recent funding milestone for Starling Medical is its $3.40M Seed Round investment on 27 January 2023. Notably, the list of investors in this round includes Gaingels, Y Combinator, Capital Factory, Innospark Ventures, Magic Fund, Rebel Fund, Modi Ventures, Praxis Spinal Cord Institute, Rogers Family Foundation, and REMY Ventures. These developments clearly position Starling Medical as a promising player in the Health Care and Medical Devices industries, with potential for significant impact in the field of remote patient monitoring and chronic disease management.

Funding Stage	Amount	Investors	Lead Investors	Date
Seed Round	$3.40M	10	Gaingels, Y Combinator +8	27 Jan 2023
Pre Seed Round	$500.00K	-		22 Mar 2022
Grant	$50.00K	-		20 May 2021
Grant	$255.99K	-		30 Nov 2020
Non Equity Assistance	$25.00K	-		21 Oct 2020

Funding Stage

Amount

Investors

Lead Investors

Date

Seed Round

$3.40M

Gaingels, Y Combinator +8

27 Jan 2023

Pre Seed Round

$500.00K

22 Mar 2022

Grant

$50.00K

20 May 2021

Grant

$255.99K

30 Nov 2020

Non Equity Assistance

$25.00K

21 Oct 2020

FAQ About Starling (YC W22)

An AI-powered at home urology remote patient monitoring platform

Starling (YC W22) was founded in 2019.

Starling (YC W22) is headquartered in Houston, United States.

Starling (YC W22) operates in Health Care and Medical Devices. Its work centres on AI-powered, remote patient monitoring, at-home medical diagnostics and urine analysis.

Starling (YC W22) has approximately 12 employees.

Starling (YC W22) has completed 5 funding rounds, raising a total of $4.23M. The latest funding stage is Seed.

Top alternatives and competitors to Starling (YC W22) include Onera Health, Usense, Aktiia, Lab Me Analytics, Olive Diagnostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Starling (YC W22) and Onera Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Starling (YC W22)

Funding Rounds & Investors (5)

Starling (YC W22) Alternatives & Competitors

FAQ About Starling (YC W22)